chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced significant pain at injection site with functional ability in right arm diminished beginning 2 hours following initial dose. Pain reduced each day and fully dissipated by day 4. Patient woke up on day 7 following initial vaccine dose with new moderate pain at injection site; unable to comfortably raise arm past shoulder height.  By mid-morning area around injection site was itchy which became more noticeable  throughout the day.  By evening a rash slightly bumpy rash developed  about 3 -4 inches in diameter. Muscle pain around injection  site reduced on day 8, mild and sporadic itching continued with prominent rash. Rash did not change size.  On day 9 following injection,  injection site is only slightly uncomfortable to touch, very mild  itching still around the top area of the injection site and rash remains.
Blood Clots Face Cheek getting Paralyzed ( Turn Black)  Painful Heart Problems ( Cardiologist )
Fever, chills, migraine, entire body aches, muscle pain, weakness , fatigue and restlessness for a full 24 hours
SHAKING WHICH STARTS IN HIS STOMACH AND MOVES TO HIS CHEST AND THEN EVENTUALLY AFFECTS HIS WHOLE BODY/WHOLE BODY SHAKING SIMILAR TO PARKINSONS; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 55 year old male. The patient's height, and weight were not reported. The patient's past medical history included: rectal cancer, and stroke, and concurrent conditions included: sulfur and codeine allergy, no alcohol use, and non smoker, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, atorvastatin, clopidogrel bisulfate, docusate, famotidine, losartan, metoprolol succinate, and tamsulosin. On 01-APR-2021, the patient experienced flu like symptoms. On 06-APR-2021, the patient experienced shaking which starts in his stomach and moves to his chest and then eventually affects his whole body/whole body shaking similar to parkinsons. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Negative, Negative, Negative, CT scan (NR: not provided) not reported, not reported, and MRI (NR: not provided) not reported, not reported, not reported. Treatment medications (dates unspecified) included: cannabidiol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 07-APR-2021, and had not recovered from shaking which starts in his stomach and moves to his chest and then eventually affects his whole body/whole body shaking similar to parkinsons. This report was non-serious. This case, from the same reporter is linked to 20220147012 and 20220147068.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
muscle aches; fatigue; fever; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (muscle aches), FATIGUE (fatigue), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (muscle aches), FATIGUE (fatigue), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (muscle aches), FATIGUE (fatigue), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.   This case was linked to MOD-2021-057858 (Patient Link).
Breastfeeding mother got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding mother got the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding mother got the vaccine). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding mother got the vaccine) had resolved.            concomitant medications list was not provided. Treatment information was not provided.   Patient had a 6-month-old and just got her Moderna Covid19 vaccine. She was wondering if there was data about transmitting through breast milk and even though she was vaccinated can she still possibly transmit the virus to her baby.
High Blood Sugar. Pt coming from home for hyperglycemia since yesterday. BS 438 enroute, been off meds since september per PCP. HPI. 40 yo m via ems with hyperglycemia.  Patient does have a history of insulin-dependent diabetes however due to improvement in his condition his insulin was discontinued several months ago.  Notes that he has been having polydipsia and polyuria and checked his blood sugar which was elevated at home.  Additionally notes recent unintended weight loss. He denies vomiting, headache, shortness of breath, LOC, and cyanosis.Review of Systems Constitutional:  No fevers or chills. Eyes:  No visual changes or discharge.ENMT:  No ear or nasal discharge. No neck pain or stiffness.Cardiac:  No chest pain or edema. Respiratory:  No cough SOB or respiratory distress. GI:  No nausea, vomiting, diarrhea or abdominal pain.GU: See history of present illnessMS:  No edema or pain. No back pain.Neuro:  No headache or weakness.  No LOC. Skin:  No skin rash.Patient's Medications.
Swelling, redness and induration of left thigh, no fever, warm to palpation. Tx Prednisolone x Augmentin x 10d. Pt received Hep A and Hib on LL, Dtap and PCV RL.
Fainting spells occured the following day and persisted over the course of 3 days. Food not tasting normal, this symtom lasted a week. Bad taste in my mouth- metallic, lasting 3 days. Hypertension, this symtom is ongoing off and on. I typically have low Blood Pressure. Dizzy spells- this symtom persists still. Vomiting- this symtom persists still. Nausea- this symtom persists still.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021 at 1:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). On 03-Nov-2021 at 1:00 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was reported as 67.94. Concomitant products were not provided. For Lot no : 035C21A on 03-Nov-2021, excursion time was 10 AM and temperature was 35 respectively, total doses given for the day was 117, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 05-Oct-2021 and was moved to clinic on  03-Nov-2021. 6 vials was sent to clinic. Vaccine BUD date was 05-Nov-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Pt complained of myalgia accompanied with a low temperature fever lasting over three days after administration of vaccination.
Chills; feels like animals are crawling on her; blisters; scratches the blisters, they start to burn; scratches the blisters, they start to burn; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (feels like animals are crawling on her), BLISTER (blisters), SKIN BURNING SENSATION (scratches the blisters, they start to burn), RASH VESICULAR (scratches the blisters, they start to burn) and CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced FORMICATION (feels like animals are crawling on her), BLISTER (blisters), SKIN BURNING SENSATION (scratches the blisters, they start to burn) and RASH VESICULAR (scratches the blisters, they start to burn). On 16-Feb-2021, the patient experienced CHILLS (Chills). The patient was treated with PREDNISONE at a dose of 1 dosage form and HYDROCORTISONE (topical) at a dose of 2.5 %. At the time of the report, FORMICATION (feels like animals are crawling on her), BLISTER (blisters), SKIN BURNING SENSATION (scratches the blisters, they start to burn), RASH VESICULAR (scratches the blisters, they start to burn) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was provided.   This case was linked to MOD-2021-155006 (Patient Link).
Administered expired vaccines; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2022: Follow up received contains no new information.
Patient developed lump at injection several hours after receiving vaccine.  The next day,  patient  started to develop swelling in the left armpit/lymph node.   The swelling continued to get worse and become painful.  After the patient showed me the swelling, I suggested that they be evaluated at clinic care or the ER if unable to contact their PCP.  In the meantime,  I recommended that he take Benadryl and ice the affected area.
Received vaccine on 6/27/06.  Within 24 hours began with moderate diarrhea and vomiting.  This persisted and progressed to projectile vomiting and inability to tolerate feeds.  Patient had an upper GI performed on 7/13/06 showing overactive peristalsis and antral spasms.  He gradually improved and by 7/19/06 was tolerating formula again.  My concern is the prolonged duration and the severity of the vomiting and diarrhea after the vaccine.  He did not manifest any fever, show any other viral symptoms or have any ill contacts to otherwise explain this reaction.
Severe pain in joints/mussels and skin surface.  Sleep walking and hallucinations.
Redness at injection site, increasing in size to 2 3/4" X 3".
7/6 1:30AM fever to 103 degrees - all day - nausea, headache.  F/u clinic visit -  after blood draw.
Pt reported itchy red bumps covering entire body head to toe which started late Saturday 10/7/17 and fully developed on Sunday 10/8/2017. Pt  got medical attention on Monday 10/9/2017 - received steroid shot. Got better but still has some redness at the time of encounter on 10/13/2017.
4 hours after vaccination, patient reports feeling shortness of breath, palpitations, lightheaded, shivering, and almost fainted. Symptoms lasted 30 mins and resolved but returned. He called 911 and went to Hoag hospital. Patient was seen and released but symptoms reoccurred after he got home so he went again. He was administered diphenhydramine 50mg IVP at 12/19, 2136; famotidine 20mg IVP at 12/19, 2136, lorazepam 0.5mg IVP at 12/19 2136 and started on lactated ringers 1000ml bolus at 12/19, 2138. He was discharged on 12/19 after symptoms resolved.
5 to 10 minutes after this dose, the patient experienced sharp pain in both ears. The pain has occurred again intermittently since then.  She is in clinic today for her 2nd dose and 30 minutes post-vaccination she is denying any
SHAKES; WEAKNESS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced shakes. On 10-MAR-2021, the subject experienced weakness. On 10-MAR-2021, the subject experienced headache. On 10-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakes, headache, nausea, and weakness. This report was non-serious.
Vaccine expired on 05/25/2021 and was administered on 05/27/2021
pt recv vax 13NOV98 & about 1/2hr p/vax exp tingling rt side of neck & side of tongue;also aching cheek bone;
Received vaccine at 13:30, went home and by 19:30 hives were present on the abdomen, extremities, back and neck. Saw physician on 12/21/04 at 13:30, had taken Benadryl until seen by MD. Hives reoccurred that evening, 12/21/04 and patient again started Benadryl and Tylenol. No further follow up recommended, hives resolved by 12/22/04.
Pain at site of injection around 8:00 PM. No discomfort prior to that. Progressively worsened all night. Swelling down to elbow. Went to ER at 5:00 AM due to extreme pain. Treated with steroids and BENADRYL through IV. Left around 7:30. Swelling continued over next few days and traveled down through hand. By 1-22 arm was normal.
Administration of vaccine past published expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter.  The HCP stated that 19 patients were administered on 29Mar2022, 30Mar2022, 31Mar2022, 01Apr2022 and 04Apr2022.  On 01 Apr 2022, the vial was initially stored in the refrigerator and thawed on the day of use. The administration was spread out throughout the end of March to the beginning of April.  The vial did not undergo any temperature excursions.  Treatment information was not provided.
cramps; back aches; bone aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramps), BACK PAIN (back aches) and BONE PAIN (bone aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 070B21) for COVID-19 vaccination.     The patient's past medical history included High risk pregnancy (She had a condition where the placenta separates from the uterus.), Breast cancer stage III (She had breast reconstruction, She was on Chemo and had radiation), Tumor (Tumor in the spine that had to be removed.), Polyps (Polyps in the uterus), Cyst and Breast reconstruction on 10-May-2021. Concomitant products included TAMOXIFEN, GABAPENTIN and TRAZODONE for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (cramps), BACK PAIN (back aches) and BONE PAIN (bone aches). At the time of the report, MUSCLE SPASMS (cramps), BACK PAIN (back aches) and BONE PAIN (bone aches) outcome was unknown.            No treatment information was provided.
Febrile illness on 8/14-resolved that day rash 8/18: multiple target lesions, some coalescing, some papular, many with central duskiness; no mucous membrane involvement: rash c/w erythema multimorme.
numbness @ inj site, radiating up neck 30MAR95; nl ROM; tx Anaprox; 4APR95 residual stiffness in neck-good ROM & flexion; minimal edema;
Her arm became very red, hot to the touch, itchy, and got some type of raised bumps. She was out of sorts and very tearful. The urgent care Dr. measured the redness on her arm at 10cmX8cm.
Onset beginning 1 day post vax. Flu-like symptoms 2-3 days post vax. Swelling in arm 4-5 days and localized approximately 5 inches across.
Syncopal episode twice. One episode on 9/12/16 and one on 9/30/16. Was treated with rest, anti nausea medications and IV fluids. Headache and vomiting and sore arm the night of the vaccine and for 2 days after. (Aug 22, 2016-Aug 25, 2016) Has had episodic vomiting every 2-3 days since the vaccination.
Right shoulder and upper arm is red, swollen and hot. Entire area is extremely painful requiring ice pack and antiinflammatories. Sleep is difficult due to pain and swelling.
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On an unknown date, the patient was administered a dose of ROTATEQ (2 ml, via oral route of administration, lot # J012954, expiration date: 31-MAR-2015) post temperature excursion. Excursion was supported. No adverse events were reported. Additional information has been requested.
The patient told me she gets dizzy after vaccine. I told her to remain in chair and to call me if she needed anything. A few minutes later she told me she felt like she was going to pass out. I got my tech to stay w/her so she wouldn't hit the floor, we got her some water. My tech told me she was having a seizure and I called 911 (EMS) to come. She precoded her mother's phone number before this and I called her mom to come to the pharmacy. I called her mother again when she was on the way and let her know I called 911 and EMS was coming. After her mom got here I was told to cancel EMS which I did the patient had her arms pulled up to her, eyes rolled, and patient urinated per tech. Her mother stayed and then they left together. Patient also told tech that she did fine with last year's flu shot.
skin was significantly hot and swollen to the wrist; skin was significantly hot and swollen to the wrist; red line to lower arm; Information has been received from a nurse referring to a 68 years old male patient (a dentist). The patient was administered pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) one year ago. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided.  On 12-NOV-2019, the patient was administered his first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot number R012360, expiration date 15-JAN-2020; frequency, anatomical location and route of administration were unknown) for prophylaxis.   On the same date, after receiving the injection the patient developed a reaction at the injection site that his skin was significantly hot and swollen to the wrist. A red line had formed on the lower arm. On 14-NOV-2019, the patient saw an infectious disease specialist and was given antiobiotics for treatment.  The outcome of events was reported as not recovered. The causality assessment was not reported.
Patient received first Pfizer dose. She was sitting in the waiting room for about 10 minutes. Got up to get a drink and started to feel faint. She passed out and her sister caught her and eased her down to the floor. By the time we were notified she had already came to. She said she was nauseous, tingly, pale looking but was sitting up and awake.  EMT came and looked her over and they cleared her to go and she left on her own with her mom.
No adverse events have been reported. The patient was erroneously given this vaccine. He had a dose of this vaccine on 4/20/2017, so was not due to receive another dose.
arrative: This patient received two doses of Pizer COVID 19 Vaccine in Mar/Apr 2021. The patient tested positive for COVID 19 on 23 December 2021/ The patient was admitted to the hospital on 29 December 2021 with cough, fever, shortness of breath, hypoxia, and was diagnosed with COVID pneumonia. The patient was treated with remdesivir and dexamethasone. The patient was discharged on oxygen on 2 Jan 2022. Reported per EUA.
Determined to be paralytic polio as of 10/23/01 by a panel of national experts outside the CDC.
Information has been received from a pharmacist via Pfizer Inc (Manufacturer report # 2015266508), referring to a patient of unknown age and gender, with metastatic breast cancer and lupus. On an unknown date, the patient was vaccinated with PNEUMOVAX 23, (dose, route of administration, lot # and expiration date were not provided), and subsequently developed an allergy to the vaccine. At the time of reporting, the outcome of the allergy to vaccine was unknown. Additional information is not expected because no consent for follow up was given by the reporter.